Adovate develops novel drugs that target adenosine receptors involved in major diseases. These drug candidates are created using an adenosine drug development platform that enables the design of patented compounds with favorable physiochemical characteristics and distribution kinetics that historically limited drugs acting against the adenosine receptors.
Adovate develops novel drugs that target adenosine receptors involved in major diseases. These drug candidates are created using an adenosine drug development platform that enables the design of patented compounds with favorable physiochemical characteristics and distribution kinetics that historically limited drugs acting against the adenosine receptors.
Finch Pharma is developing methods of delivering Nitric Oxide (NO) using silicon nano-pods. SNO-pods have varied therapeutic applications, including wound-healing, burns, acne, alopecia, sinusitis, onychomycosis (nail fungus), erectile dysfunction, hemorrhoids/anal fissures, and diaper rash.
Finch Pharma is developing methods of delivering Nitric Oxide (NO) using silicon nano-pods. SNO-pods have varied therapeutic applications, including wound-healing, burns, acne, alopecia, sinusitis, onychomycosis (nail fungus), erectile dysfunction, hemorrhoids/anal fissures, and diaper rash.